Why the study?
To evaluate and compare the ultrasonographic changes associated with hepatosteatosis in diabetic obese versus diabetic normal-weight patients.
Are ultrasonographic features of hepatosteatosis more prevalent in diabetic obese patients compared to diabetic normal-weight patients?
Are ultrasonographic features of hepatosteatosis more prevalent in diabetic obese patients compared to diabetic normal-weight patients?
Diabetic obese patients have a higher risk of developing hepatosteatosis compared to diabetic patients with a normal BMI.
Ultrasonographic hepatosteatosis assessment in diabetes by weight status remains hypothesis-generating; leaves open independent obesity effects and any practice change.
BACKGROUND: The purpose of the study is to evaluate and compare the changes associated with hepatosteatosis in diabetic obese versus diabetic normal-weight patients through ultrasonography. It is estimated that with the prevalence of about 30%-75% of obese individuals accordingto the body mass index (BMI) criteria are at increase risk of developing simple fatty live. Besides obesity, diabetes mellitus is also considered to be one of the important causes of hepatosteatosis. Chi-square tests were applied to compare the frequencies of fatty changes, border, and surface characteristics. CONCLUSION: It is concluded that diabetic obese patients are more prone to develop hepatosteatosis as compared to normal BMI diabetic individuals.
No takes yet. Share an insight, caveat, or question.
Liaqat et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: